Theriva Biologics Inc. (TOVX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $0.20
• Market Cap: $7.13M
• P/E Ratio: 0.10
• EPS: $2.06
• 52-Week High: $1.50
• 52-Week Low: $0.16

Market Sentiment

Theriva Biologics Inc. currently has a Bullish sentiment score of 0.45.

About Theriva Biologics Inc.

Theriva Biologics Inc. (TOVX) is a clinical-stage biotechnology company headquartered in Rockville, Maryland, dedicated to addressing significant unmet medical needs through the development of innovative biologic therapies. Utilizing its proprietary technology platforms, the company focuses on creating targeted treatment solutions that aim to enhance patient outcomes across various therapeutic areas. With a promising pipeline and a highly skilled team, Theriva is well-positioned to advance it...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Theriva Biologics Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TOVX pay dividends?

Theriva Biologics Inc. (TOVX) does not currently pay a regular dividend.

What is TOVX's P/E ratio?

Theriva Biologics Inc. has a price-to-earnings (P/E) ratio of 0.10.

What is TOVX's market cap?

Theriva Biologics Inc. (TOVX) has a market capitalization of $7.13M with a current stock price of $0.20.